The hormone regimen used to bump up egg production during in vitro fertilization (IVF) may have an effect on the blood pressure of the resulting children, according to a new analysis. The study suggests that the hormone regimen, rather than other aspects of in vitro fertilization, such as embryo culture, underlies findings indicating that the cardiometabolic health of offspring is compromised.
The hormone regimen used to bump up egg production during in vitro fertilization (IVF) may have an effect on the blood pressure of the resulting children, according to a new analysis. The study suggests that the hormone regimen, rather than other aspects of in vitro fertilization, such as embryo culture, underlies findings indicating that the cardiometabolic health of offspring is compromised.
Three studies have reported elevated blood pressure in IVF children, though two studies have not seen such an effect. The two studies, however, showed other problems with cardiometabolic health, such as an increased risk of vascular dysfunction. Overall, the data hint that children born from IVF have poorer cardiometabolic outcomes than children conceived naturally-a difference that is not attributable to factors such as prematurity or low birth weight, which also occur more frequently in IVF offspring.
In the two new analyses, Jorien Seggers et al. and Sacha La Bastide-Van Gemert et al. examined systolic blood pressure in 194 children conceived using different methods and crunched the data using two separate statistical approaches. Both analyses showed that children born from IVF following controlled ovarian hyperstimulation (a hormonal regimen that boosts ovulation rate) had higher blood pressure at age four than children born from modified natural-cycle IVF, which does not involve the same hormonal procedures. The difference was about 13 percentile points and was not due to factors such as weight of the mother. The data also hinted that IVF children conceived through ovarian hyperstimulation may also have slightly more subcutaneous fat, an indicator of poor metabolic health.
The findings suggest that the hormonal boost of conventional IVF procedures may affect the health of the oocyte and ultimately the health of the resulting offspring. This conclusion was bolstered by the observation that there was no difference in blood pressure between children from modified natural-cycle IVF and children conceived naturally by subfertile couples, suggesting that the in vitro aspects of the procedure did not affect blood pressure.
The researchers speculate that ovarian hyperstimulation might have epigenetic effects on the DNA of the oocyte, which undergoes epigenetic modifications during maturation. They point to studies in mice suggesting that ovarian hyperstimulation results in epigenetic disturbances, and studies in humans showing that IVF is associated with epigenetic modifications in phenotypically normal offspring.
The findings raise many basic research questions, but also highlight the need for further clinical studies. The new studies also suffer from several drawbacks; for instance, there was a low number of study subjects, and the researchers could not rule out an effect due to the criteria used to select women to receive hyperstimulation versus natural-cycle IVF. Geneticists have applied a pioneer DNA sequencing technique to determine the genetic makeup of single human oocytes. The DNA is collected from polar bodies extruded from the oocyte, showcasing the technique as a noninvasive way to screen an egg's genes prior to assisted reproduction.
Current methods to assess oocyte or embryo DNA for assisted reproduction are limited. One common method involves removing a cell from the early embryo and checking its DNA for gross abnormalities, such as missing chromosomes. But this method of pre-implantation genetic diagnosis has drawbacks, including that it requires microsurgery of the embryo, there are concerns that it may disrupt development, and it has not been possible to simultaneously obtain both sequence data and information on aneuploidy.
In the new study, Yu Hou et al. deployed a technique recently developed to sequence DNA from a single cell. The technique involves a unique step that enables uniform levels of DNA amplification, regardless of sequence, called multiple annealing and looping-based amplification cycles (MALBAC). MALBAC overcomes the problem of amplification bias that has plagued previous methods of single-cell sequencing.
Using oocytes donated by eight healthy women, the researchers found that by sequencing the DNA of the polar bodies, they could predict the sequence of the DNA in the oocyte pronucleus. Using DNA information from the polar bodies, the researchers could accurately identify 91 to 95 percent of single nucleotide polymorphisms (SNPs) in the pronucleus in each donor. The technique also enabled the researchers to detect chromosomal abnormalities, such as extra or missing chromosomes and translocations.
The cost of detecting these larger-scale changes is about the same as that of current methods of pre-implantation genetic diagnosis, the researchers say. Whole-genome sequencing, however, is much more costly and technologies will have to improve for that approach to become feasible on a large scale. Meanwhile, the researchers have begun a small clinical trial to determine whether the method improves the success rates of in vitro fertilization in women who have genetic diseases or who have suffered multiple miscarriages.
The technique not only has clinical potential, but it also will enable researchers to answer longstanding basic research questions. For instance, in the current study, the researchers calculated that the average rate of chromosome crossover in the oocyte was 43 crossovers per haploid cell-about 1.65 times that of sperm. A molecular complex has been identified that promotes the survival of oocytes. Deleting components of the cullin-ring finger ligase-4 (CRL4) complex leads to a phenotype in mice similar to primary ovarian insufficiency, a form of infertility in which women run out of oocytes before age 40.
The Pten/Foxo3a pathway, which previous studies have homed in on, is a signaling pathway that affects ovarian aging. It keeps primordial follicles quiet, preventing them from prematurely activating and developing into mature oocytes. In the absence of this pathway, the pool of immature follicles is activated and rapidly depleted.
CRL4 operates differently, in that it is required for development and maintenance of the oocytes in the primordial follicle population. Chao Yu et al. deleted components of this complex in oocytes in mice shortly after birth and, as a result, the oocytes underwent apoptosis and the ovaries shrank. By young adulthood, the primary follicle population was depleted in these mice-a phenotype closely resembling primary ovarian insufficiency.
What is remarkable is that this loss in the ovarian reserve was not due to wholesale activation of the primordial follicle population, as occurs in mice deficient in Pten or Foxo3a. Rather, it resulted from the demise of the oocytes in these primary follicles.
The researchers showed that CRL4 seems to function, at least in part, by binding to TET methylcytosine dioxygenases, which are known to regulate the activity of genes involved in oocyte development and maintenance. The binding of CRL4 to TET proteins fosters their ability to bind DNA and promote gene transcription.
CRL complexes can function simply as scaffolding proteins, as in this study, but they are perhaps best known for seeding protein ubiquitination. Uncovering other substrates of CRL4 in the oocyte should help researchers to delve deeper into the question of what keeps oocytes alive through their many years of dormancy in the ovary. The phenotypic effect of many genetic variants depends on whether they originated from an individual's mother or father, according to a new study in mice. The findings show that parent-oforigin effects are much more powerful than previously thought, modifying longstanding views of Mendelian inheritance.
Geneticists are becoming more adept at assigning heritability to specific genetic variants-that is, at determining how much the variant contributes to a specific phenotypic trait. Richard Mott and colleagues have developed a sophisticated system for assessing heritability using a stock of mice with defined genetic heterogeneity that is amenable to genetic analysis. The researchers previously measured 97 phenotypic traits in this population and identified genetic loci associated with these traits, called quantitative trait loci (QTLs). The researchers have now assessed the contribution of parent-of-origin to the heritability of these traits.
One way to measure heritability is to correlate the extent of allelesharing between individuals with their phenotypic similarity. High heritability means high correlation. The authors then added another layer of analysis, which involved determining the parent-of-origin of identical alleles in a population. Using this method, the researchers found that almost all 97 traits showed parent-of-origin effects. The researchers also examined 837 QTLs linked to these traits and found that more than half showed different effects on heritability depending on whether they originated with the mother or the father.
The researchers next drew a link between their observations and imprinting, in which the allele from either the mother or the father is silenced by methylation. Only a handful of genes-fewer than 100 in humans-are known to be imprinted. But could interactions with imprinted genes explain such surprisingly common parent-of-origin effects?
In one experiment, the researchers closely examined offspring of crosses containing a knockout in a genomic region that showed parentof-origin effects (this region did not contain imprinted genes). They observed widespread changes in gene expression that depended on the parental origin of the knockout. Moreover, some known imprinted genes had their expression altered.
The authors propose that non-imprinted genes can modify the expression of imprinted genes, producing ripple effects on gene expression throughout the genome. As a result, the effect of most genes is dependent on whether they were inherited from the mother or the father.
The findings have far-reaching implications. As just one example, the findings suggest that phenotypic similarity between siblings, particularly twins, is due not only to their similar genetic makeup, but also to their inheriting sets of genes from the same parent. Therefore, the new findings could at least partly explain why genome-wide association studies have generally produced estimates of heritability that are lower than those of sibling-based studies. This problem of ''missing heritability'' has long vexed geneticists, and is a major area of investigation.
Further probing this question, as well as others-such as the molecular basis of the parent-of-origin effects observed in this studywill surely yield yet more surprises. Seminal fluid exerts an effect on the female reproductive tract and may influence the epigenetic programming of the early embryo, a new study in mice suggests.
Previous studies have shown that seminal fluid contains signaling factors known to affect development. Some of these factors induce the female reproductive tract to synthesize molecules such as GM-CSF (granulocyte macrophage colony-stimulating factor), which is believed to affect embryo growth and promote immunologic tolerance.
To investigate the role of seminal fluid, John Bromfield et al. surgically removed the seminal vesicle gland from males prior to mating. The researchers observed effects on multiple aspects of fertility and development; for instance, many of the embryos failed to develop past the eight-cell stage, and the placentas of the offspring were unusually heavy. Moreover, the adult offspring had high rates of obesity and hypertension, aberrant levels of metabolic hormones, and reduced glucose tolerance. The effect was most pronounced in male offspring, which are known to be more susceptible to various environmental perturbations during early embryonic development.
Seminal fluid is known to protect DNA from oxidative damage, and there are hints that it may also affect the epigenetic status of sperm. But some of the phenotypes observed could also be due to the absence of seminal fluid's natural effect on the female reproductive tract. The researchers addressed this question in two ways.
First, female mice were mated with males lacking seminal fluid. The researchers flushed out the resulting two-cell embryos and grew them in culture. This process rescued many of the early-stage defects, with a high rate of survival to the blastocyst stage.
Second, the researchers transferred normal two-cell embryos into females mated with males that were surgically altered to not make SCHUBERT seminal fluid or sperm. The adult male offspring were chubby-with 28 percent more central fat than control males, whose fathers produced seminal fluid-though some of the other metabolic changes were not evident. The effects were not observed when embryos were transferred at the blastocyst stage, suggesting that seminal fluid exerts its effects in the early cleavage stages.
Seminal fluid seems to operate by affecting an abundance of factors in the oviduct known to affect embryonic development, such as GM-CSF and LIF (leukemia inhibitory factor). The researchers speculate that some of these factors convey epigenetic information to the embryo during the early cleavage stages, when the embryonic DNA is undergoing epigenomic reprogramming.
The findings are consistent with emerging studies showing that a male's stress, chemical exposures, and dietary conditions can affect his offspring.
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